Novartis Investigative Site

Mitaka, Tokyo 181-8611

0 studies enrolling now · 5 studies all time

What they study most

Advanced Gastric Cancer, Carcinoma, Pulmonary Arterial Hypertension, Treatment-Resistant Depression, Uveitis

Studies at this site

• Study of Efficacy, Safety, Tolerability and Pharmacokinetics of MIJ821 in Participants With Treatment- Resistant Depression (TRD) — Completed
• Global Study Looking at the Combination of RAD001 Plus Best Supportive Care (BSC) and Placebo Plus BSC to Treat Patients With Advanced Hepatocellular Carcinoma. — Completed
• Safety and Efficacy of RAD001 (Everolimus) Monotherapy Plus Best Supportive Care in Patients With Advanced Gastric Cancer (AGC) — Completed
• Safety and Efficacy of AIN457 in Patients With Active Non-infectious Uveitis — Stopped early
• Extension to QTI571A2301 to Evaluate the Long-term Safety, Tolerability and Efficacy of Imatinib in Severe Pulmonary Arterial Hypertension (PAH) — Stopped early